NEW YORK--(BUSINESS WIRE)--Feb 12, 2026-- ...
Net proceeds from the offering will fully fund the Company through its initial exploration plan over the next two years The transaction was ...
Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile